This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Medgenics, Inc. (the “Company”) Issue Of Options And Restricted Shares To Directors And Officers

Stocks in this article: MDGN MEDG

This announcement is being made pursuant to the London Stock Exchange’s AIM Rules for Companies admitted to trading on the AIM market.

Following the award of the Restricted Shares and grant of the Options to the non-executive Directors, the interests of the directors of the Company and their related parties and other significant shareholders in the Common Shares of which the Company is aware will be as follows:

Name   Common Shares   % of Issued Share Capital   Instrument   Number   Expiry Date   Exercise Price   Total interests   % of Issued Share Capital

Isaac Blech(Director) & related parties 1

1,652,471 Warrant 230,357 22/9/2015 $4.54
Total Warrant 1,000,000 12/4/2016 $6.00
Options 19,068 10/12/2020 $6.65
Options 15,000 2/1/2022 $2.66
Options 15,000 2/1/2023 $7.25
7,000*                            
1,659,471 13.4% 1,279,425 2,938,896 23.8%
 
Joel S. Kanter (Director) & related parties 2 1,207,332 Warrant 26,785 22/9/2015 $4.54
Warrant 15,540 12/4/2016 $4.99
Options 8,571 11/1/2021 $6.55
Options 28,571 14/9/2020 $8.19
Options 15,000 2/1/2022 $2.66
Options 15,000 2/1/2023 $7.25
7,000*                            
Total 1,214,332 9.8% Options 109,377 1,323,709 10.7%
 
Andrew L. Pearlman (Director) & related parties 4 35,375 Warrant 35,922 31/3/2016 $0.0002
Warrant 682,240 31/3/2016 $2.49
Options 182,806 31/3/2016 $2.49
Options 80,000 9/12/2021 $3.14
                             
Total 35,375 0.3% 980,968 1,016,343 8.2%%
 
Beryl Steinberg 621,443 Warrant 21,885

12/4/2016

$4.99
                             
Total 621,443 5.0% 21,885 643,328 5.2%
 
Chicago Investments, Inc. 3 637,008 Warrant 5,357 22/9/2015 $4.54
        Warrant   8,368   12/4/2016   $4.99        
Total 637,008 5.2% 13,725 650,733 5.3%
 
Andrew Cader 788,950       Warrant   264,000   12/4/2016   $6.00        
Total 788,950 6.4% 264,000 1,052,950 8.5%
 
CIBC Trust Company (Bahamas) Limited, as Trustee of T-555 3 349,386 Warrant 10,714 22/9/2015 $4.54
        Warrant   5,150   12/4/2016   $4.99        
349,386 2.8% 15,864 365,250 3.0%
 
Eugene A. Bauer (Director) 173,017 Options 28,571 14/9/2020 $8.19
42,857*                            
Total 215,874 1.7% 28,571 244,445 2.0%
 
Stephen D. McMurray (Director) 79,835 Warrant 644 12/4/2016 $4.99
Options 12,857 11/1/2021 $6.55
Options 28,571 14/9/2020 $8.19
Options 15,000 2/1/2022 $2.66
Options 15,000 2/1/2023 $7.25
7,000*                            
Total 86,835 0.7% 72,072 158,907 1.3%
 
 
 
 
 
Sol Options 900,000 30-6-2017 $10.80
Barer

(Director)

Options 15,000 2/1/2023 $7.25
7,000*
 
Total 7,000 0.1% 915,000 922,000 7.5%
 
Alastair Clemow (Director) 7,000 Options 12,857 13/9/2020 $8.19
Options 12,857 11/1/2021 $6.55
Options 15,000 2/1/2022 $2.66
Options 15,000 2/1/2023 $7.25
7,000*                            
Total 14,000 0.1% 55,714 69,714 0.6%
 
  • Restricted shares

Notes

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,219.56 -197.29 -1.13%
S&P 500 2,004.00 -17.25 -0.85%
NASDAQ 4,652.9290 -30.4780 -0.65%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs